Sue Siegel has been named a GE corporate vice president and will serve as CEO of GE's Healthymagination of Fairfield, Conn.
Siegel, 52, joins GE from Mohr Davidow Ventures in Menlo, Calif., where she was a general partner of investments spanning technology platforms, molecular diagnostics and digital health, according to GE.
She will oversee efforts that include:
- Healthcare innovation, such as investments via the $250 million Healthymagination fund and the Healthymagination Open Innovation Challenge, initially focused on early-stage breast cancer;
- New models for health delivery, such as expanding a GE-supported Breast Cancer Screening Program in the Kingdom of Saudi Arabia and GE’s Cities Program that supports campaigns, such as Cincinnati’s Regional Health Transformation effort;
- Consumer engagement in healthy outcomes, including GE’s workplace programs and community health programs;
- Product alignment that brings learning from Healthymagination to GE’s commercial products; and
- Partnerships with various healthcare businesses, thought leaders and governments.
Prior to joining Mohr Davidow Ventures, Siegel served as president and director of Affymetrix, developer of the GeneChip technology, which propelled the expansion of the genomics field and helped the early development of personalized medicine.
She has held positions with Amersham International, now part of GE Healthcare, E.I. DuPont, Eastman Kodak and Bio-Rad, and also serves on various corporate and advisory boards including the President’s Circle of the National Academies.
Siegel succeeds Mike Barber, who held the position since 2009 and was named vice president and general manager of molecular imaging at GE Healthcare.